Your browser doesn't support javascript.
loading
Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause.
Tzartos, John; Pechlivanidou, Maria; Bosveli, Despoina; Ninou, Elpinickie; Yuceer, Hande; Yalcin, Beyzanur; Kucukali, Cem Ismail; Tuzun, Erdem; Tzartos, Socrates; Turkdogan, Dilsad.
Afiliação
  • Tzartos J; 2 Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" University Hospital, Athens, Greece.
  • Pechlivanidou M; Tzartos NeuroDiagnostics, Athens, Greece.
  • Bosveli D; Tzartos NeuroDiagnostics, Athens, Greece.
  • Ninou E; Tzartos NeuroDiagnostics, Athens, Greece.
  • Yuceer H; Department of Neuroscience, Aziz Sancar Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey.
  • Yalcin B; Department of Neuroscience, Aziz Sancar Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey.
  • Kucukali CI; Department of Neuroscience, Aziz Sancar Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey.
  • Tuzun E; Department of Neuroscience, Aziz Sancar Institute for Experimental Medical Research, Istanbul University, Istanbul, Turkey; drerdem@yahoo.com.
  • Tzartos S; Tzartos NeuroDiagnostics, Athens, Greece.
  • Turkdogan D; Department of Neurobiology, Hellenic Pasteur Institute, Athens, Greece.
In Vivo ; 38(1): 351-357, 2024.
Article em En | MEDLINE | ID: mdl-38148071
ABSTRACT
BACKGROUND/

AIM:

Kelch-like protein 11 (KLHL11)-antibody may be found in paraneoplastic neurological disorders presenting with epileptic seizures. The aim of this study was to investigate the prevalence and clinical significance of KLHL11-antibody in epilepsy. PATIENTS AND

METHODS:

Sera of 42 pediatric and 59 adult patients with seizures of undetermined cause were screened using a cell-based assay.

RESULTS:

KLHL11-antibody was found in three of 168 control patients with paraneoplastic neurological disorders and four pediatric patients (4-8-year-old, 2 boys/2 girls) with seizures of unknown cause presenting with myoclonic-atonic epilepsy, generalized epilepsy or childhood epilepsy with centrotemporal spikes. In these four cases, seizures continued for 2-7 months, responded promptly and favorably to conventional anti-seizure drugs and did not recur in follow-up durations ranging between 2-5 years. Patients had normal brain MRI findings and motor-mental development before and after seizures. KLHL11-antibody was not detected in adult epilepsy patients with undetermined cause, MOG antibody-positive patients and healthy controls.

CONCLUSION:

KLHL11-antibody may be detected in pediatric epilepsy patients with a relatively benign disease course.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eletroencefalografia / Epilepsia Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eletroencefalografia / Epilepsia Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article